World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
16387
World Ranking
2012
National Ranking
24

Jan Poolman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jan Poolman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 238 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jan Poolman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jan Poolman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jan Poolman is a researcher affiliated with Janssen in Belgium whose work primarily intersects the fields of biochemistry, genetics, molecular biology, and medicine. Their research spans multiple subfields, including endocrinology, epidemiology, molecular medicine, molecular biology, and infectious diseases.

The scientist has contributed extensively to topics related to Escherichia coli research studies, antibiotic resistance in bacteria, and urinary tract infection management. Other notable research areas include gut microbiota and health, enterobacteriaceae and Cronobacter research, bacterial infections and vaccines, and bacterial identification and susceptibility testing.

Jan Poolman has published several papers, reflecting the focus and progression of their scientific inquiries. Recent selected publications include:

  • "Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review," 2020, Clinical Infectious Diseases
  • "Genomics and pathotypes of the many faces of Escherichia coli," 2022, FEMS Microbiology Reviews
  • "Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines," 2021, npj Vaccines
  • "Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections," 2020, npj Vaccines
  • "Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies," 2022, Clinical Infectious Diseases

Frequent collaboration has been a feature of Poolman's career, working notably with coauthors such as Jeroen Geurtsen, Bart Spiessens, Oscar Go, Marc J. M. Bonten, and Michal Sarnecki.

Their research findings have been disseminated particularly in journals like Open Forum Infectious Diseases, npj Vaccines, Clinical Infectious Diseases, Vaccine, and The Journal of Urology. These venues have hosted multiple publications by Poolman, highlighting an ongoing engagement with infectious disease research and vaccine development.

Best Publications

  • Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

    Roman Prymula;Pascal Peeters;Viktor Chrobok;Pavla Kriz

  • Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

    Carl E. Frasch;Wendell D. Zollinger;Jan T. Poolman

  • Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.

    Jordan W. Tappero;Rosanna Lagos;Aurora Maldonado Ballesteros;Brian Plikaytis

  • Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies

    Hussein Abdillahi;Jan T. Poolman

  • Description and nomenclature of Neisseria meningitidis capsule locus.

    Odile B. Harrison;Heike Claus;Ying Jiang;Julia S. Bennett

  • Glycoconjugate vaccines and immune interference: A review

    Ron Dagan;Jan Poolman;Claire-Anne Siegrist

  • Extraintestinal Pathogenic Escherichia Coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

    Jan T. Poolman;Michael Wacker

  • Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review.

    Marc Bonten;James R Johnson;Anita H J van den Biggelaar;Leonidas Georgalis

  • Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.

    R. Borrow;G.M. Carlone;N. Rosenstein;M. Blake

  • Point mutation in meningococcal por A gene associated with increased endemic disease.

    B.T. McGuinness;I.N. Clarke;P.R. Lambden;A.K. Barlow

  • Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

    Keith Cartwright;Rhonwen Morris;Hans Rümke;Andrew Fox

  • Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

    Angela Csaki Huttner;Christoph Hatz;Christoph Hatz;Germie van den Dobbelsteen;Darren Abbanat

  • Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines.

    C. C. A. M. Peeters;A.-M. Tenbergen-Meekes;J. T. Poolman;M. Beurret

  • Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China.

    J F Wang;D A Caugant;X Li;X Hu

  • Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay.

    K. Saukkonen;M. Leinonen;H. Abdillahi;J.T. Poolman

  • Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines

    Jan Poolman;Raymond Borrow

  • Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA

    Abiodun David Ogunniyi;Matthew C. Woodrow;Jan T. Poolman;James C. Paton

  • Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development.

    Kirsi Saukkonen;Hussein Abdillahi;Jan T. Poolman;Maija Leinonen

  • Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA.

    Hussein Abdillahi;Jan T. Poolman

  • Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.

    Brian McGuinness;Ann K. Barlow;Ian N. Clarke;John E. Farley

  • Heterogeneity in Diphtheria-Tetanus–Acellular Pertussis Vaccine–Specific Cellular Immunity during Infancy: Relationship to Variations in the Kinetics of Postnatal Maturation of Systemic Th1 Function

    J. Rowe;C. Macaubas;T. Monger;B.J. Holt

Frequent Co-Authors

Helena Käyhty
Helena Käyhty Finnish Institute for Health and Welfare (THL)
Lode Schuerman
Lode Schuerman GlaxoSmithKline (United Kingdom)
J. H. Van Boom
J. H. Van Boom Leiden University
G. A. Van Der Marel
G. A. Van Der Marel Leiden University
C. A. A. Van Boeckel
C. A. A. Van Boeckel Leiden University
Jan Tommassen
Jan Tommassen Utrecht University
Emmanuel J. H. J. Wiertz
Emmanuel J. H. J. Wiertz Utrecht University
Ger T. Rijkers
Ger T. Rijkers University College Roosevelt
Marc J. M. Bonten
Marc J. M. Bonten Utrecht University
Mark Achtman
Mark Achtman University of Warwick

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in combining immunology with healthcare, pursuing nursing degrees can be a strategic move. Many students explore the best online rn programs for non nurses to transition into nursing without a prior background. These online RN programs offer flexibility and a pathway to essential clinical roles.

Accelerated options are also popular for students seeking a faster route. Exploring accelerated nursing programs can help students obtain a Bachelor of Science in Nursing in a shorter time, enabling rapid entry into the nursing workforce while applying immunology knowledge practically.

For those looking for foundational licensure with quicker access into the workforce, accredited lpn programs easy to get into are an attractive option. These programs provide essential nursing skills making graduates valuable in various healthcare settings, where immunological expertise is increasingly relevant.

Finally, professionals aiming for advanced practice roles should consider the easiest online nurse practitioner programs. These degree pathways empower nurses to deliver specialized care, often incorporating immunological principles, and open doors to leadership roles in healthcare.

Best Scientists Citing Jan Poolman

Trending Scientists

Recently Published Articles